Andreas Struengmann & family

Andreas Struengmann & family (#298)

Global Rank #298

Country Rank #15

Country Germany

Andreas Struengmann & family is listed among the world billionaires tracked by Iconic Billionaires.

$ 11 B
Pharmaceuticals
Germany
M
76 Years

Snapshot

Quick Facts

Global Rank #298

Country Rank #15

Net Worth $10.9B

Previous Worth $10.9B

Worth Change +$0.0B

Country Germany

Industry Pharmaceuticals

Age 76 Years

Gender M

Worth As Of May 3, 2026

Residence Tegernsee, Germany

Citizenship Germany

World Billionaires List Germany Billionaires Pharmaceuticals

Profile Data

Personal Stats

Age 76

Source Of Wealth Pharmaceuticals, Self Made

Residence Tegernsee, Germany

Citizenship Germany

Marital Status Married

Children 2

Education Medical Doctor, University at Buffalo

Net Worth Change +$0.0B +0.0% from previous worth

Previous Net Worth $10.9B

Current Net Worth $10.9B

Worth as of May 3, 2026

About Me

Andreas Struengmann and twin brother Thomas were early backers of BioNTech, which partnered with Pfizer to make a vaccine for Covid-19. The brothers cofounded generic drugmaker Hexal in 1986 and sold it to Novartis in 2005 for some $7 billion. The brothers invest in biotech, pharma, life sciences and healthcare companies through their Zug, Switzerland-based investment firm, Santo Holding. In 2008, they established a neuroscience research center in Frankfurt named after their father, Ernst Struengmann.

Achievements

Forbes List Highlights

A snapshot of the list placements and rankings connected to Andreas Struengmann & family.

#255

Billionaires (2026)

Insights

Did You Know?

After studying medicine in Freiburg, Germany, Andreas worked as a doctor in South Africa.

Wealth Growth

Net Worth Growth Over Time

Tracking Andreas Struengmann & family's net worth journey over the years, highlighting key growth phases and financial milestones.

Worth Trend Net Worth Growth

Period Change Worth Movement

Current Net Worth: $10.9B (May 3, 2026)